Azenta, Inc. (AZTA)
As of Sep 20, 2026, Azenta, Inc. (AZTA) scores 6.6/10 on AlphaStocks' five-model composite, #23 of 168 Health Care stocks.
Health Care / Life Sciences Tools & Services
S&P SmallCap 600$33.25
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 3 of 5 models — moderate confidence
Data as of Sep 20, 2026
Is Azenta, Inc. a Good Investment in 2026?
Azenta, Inc. (AZTA) scores 6.6 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Azenta, Inc. as Attractive (5/9). The Graham model is the least favorable, rating it Neutral. Azenta, Inc. ranks #23 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is Azenta, Inc. (AZTA) a good investment?
What is Azenta, Inc.'s Piotroski F-Score?
Is AZTA overvalued or undervalued?
How does AZTA compare to other Health Care stocks?
What do investment models say about AZTA?
Similar Stocks
Compare AZTA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer